PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
POWW vs. DNA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


POWWDNA
YTD Return-42.38%-87.44%
1Y Return-51.79%-83.15%
3Y Return (Ann)-43.95%-75.86%
Sharpe Ratio-0.90-0.86
Sortino Ratio-1.26-1.94
Omega Ratio0.840.79
Calmar Ratio-0.61-0.87
Martin Ratio-1.68-1.37
Ulcer Index32.07%62.43%
Daily Std Dev60.30%99.85%
Max Drawdown-88.97%-99.10%
Current Drawdown-87.64%-98.58%

Fundamentals


POWWDNA
Market Cap$143.70M$471.84M
EPS-$0.21-$18.00
Total Revenue (TTM)$107.38M$128.91M
Gross Profit (TTM)$19.89M$59.84M
EBITDA (TTM)$51.81K-$420.68M

Correlation

-0.50.00.51.00.4

The correlation between POWW and DNA is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

POWW vs. DNA - Performance Comparison

In the year-to-date period, POWW achieves a -42.38% return, which is significantly higher than DNA's -87.44% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%20.00%JuneJulyAugustSeptemberOctoberNovember
-50.22%
-72.07%
POWW
DNA

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

POWW vs. DNA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for AMMO, Inc. (POWW) and Ginkgo Bioworks Holdings, Inc. (DNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


POWW
Sharpe ratio
The chart of Sharpe ratio for POWW, currently valued at -0.90, compared to the broader market-4.00-2.000.002.004.00-0.90
Sortino ratio
The chart of Sortino ratio for POWW, currently valued at -1.26, compared to the broader market-4.00-2.000.002.004.006.00-1.26
Omega ratio
The chart of Omega ratio for POWW, currently valued at 0.84, compared to the broader market0.501.001.502.000.84
Calmar ratio
The chart of Calmar ratio for POWW, currently valued at -0.61, compared to the broader market0.002.004.006.00-0.61
Martin ratio
The chart of Martin ratio for POWW, currently valued at -1.68, compared to the broader market0.0010.0020.0030.00-1.68
DNA
Sharpe ratio
The chart of Sharpe ratio for DNA, currently valued at -0.86, compared to the broader market-4.00-2.000.002.004.00-0.86
Sortino ratio
The chart of Sortino ratio for DNA, currently valued at -1.94, compared to the broader market-4.00-2.000.002.004.006.00-1.94
Omega ratio
The chart of Omega ratio for DNA, currently valued at 0.79, compared to the broader market0.501.001.502.000.79
Calmar ratio
The chart of Calmar ratio for DNA, currently valued at -0.87, compared to the broader market0.002.004.006.00-0.87
Martin ratio
The chart of Martin ratio for DNA, currently valued at -1.37, compared to the broader market0.0010.0020.0030.00-1.37

POWW vs. DNA - Sharpe Ratio Comparison

The current POWW Sharpe Ratio is -0.90, which is comparable to the DNA Sharpe Ratio of -0.86. The chart below compares the historical Sharpe Ratios of POWW and DNA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00JuneJulyAugustSeptemberOctoberNovember
-0.90
-0.86
POWW
DNA

Dividends

POWW vs. DNA - Dividend Comparison

Neither POWW nor DNA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

POWW vs. DNA - Drawdown Comparison

The maximum POWW drawdown since its inception was -88.97%, smaller than the maximum DNA drawdown of -99.10%. Use the drawdown chart below to compare losses from any high point for POWW and DNA. For additional features, visit the drawdowns tool.


-100.00%-95.00%-90.00%-85.00%-80.00%-75.00%JuneJulyAugustSeptemberOctoberNovember
-87.64%
-98.58%
POWW
DNA

Volatility

POWW vs. DNA - Volatility Comparison

The current volatility for AMMO, Inc. (POWW) is 17.13%, while Ginkgo Bioworks Holdings, Inc. (DNA) has a volatility of 20.35%. This indicates that POWW experiences smaller price fluctuations and is considered to be less risky than DNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%JuneJulyAugustSeptemberOctoberNovember
17.13%
20.35%
POWW
DNA

Financials

POWW vs. DNA - Financials Comparison

This section allows you to compare key financial metrics between AMMO, Inc. and Ginkgo Bioworks Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items